Infertility is not a finality!
MatriceLab’s pioneering endometrial immunology test is the result of more than 10 years of research. Combined with precision therapy, it gives women in Assisted Reproductive Therapy a better chance of successful embryo implantation.
Our mission
To increase pregnancy rates through personalized care
Our solution
Our solution
1
The goal
Establish an immune balance profile of uterine receptivity that forms the basis for a personalized therapeutic strategy promoting the success of embryonic implantation.
2
The test
An endometrial biopsy performed by your gynecologist.
3
The analysis
By identifying endometrial immunological markers, MatriceLab offers your physician targeted therapeutic options to enhance the chances of successful embryo implantation.
Our studies show a 40% to 50% birth rate, following the application of the proposed treatment, at the next embryo transfer after the MatriceLab test.*
We turned to MatriceLab on the advice of my doctor, during a several-year fertility treatment journey and after 4 failed IVF cycles.
Thanks to the immunological analysis of the endometrium, we were able to determine a care protocol and a strategy. The endometrial biopsy made it possible to prepare this strategy, followed by a course of treatments a few days before and after the egg donation.
Since then, we are the proud parents of two children born through assisted reproductive technology (ART), and more specifically thanks to the egg donor.
This testimonial was given on a personal basis; every fertility treatment journey is different and results are not guaranteed.
Our founding team
Dr Nathalie Ledee
MD in Obstetrics and Gynecology and PhD in reproductive immunology
Dr Dominique Vitoux
Alaa Kazhalawi
Marie Petitbarat
Katya Vezmar
Céline Holey
Causes of infertility
This delays the age of motherhood and fatherhood, while female fertility drops from the age of 35.
Many factors can lead to female infertility as well as male infertility: endometriosis, polycystic ovarian syndrome, tubal problems, decrease in sperm concentration or motility in the semen (it has decreased by half since the 1970s).
In 10% of cases, no cause is found. In addition, 5% of women of childbearing age have recurrent miscarriages.
Advances in research and the commitment of the public authorities, with the first national plan to combat infertility, now provide couples with numerous solutions to overcome infertility.
Causes of ART failure
The causes
The origin
The factors
The Test
Research and development
The MatriceLab team continues its research and development work to fight against infertility and to accompany patients and couples in their life projects. As an independent research and innovation laboratory, MatriceLab is developing an ever more complete and efficient pathway for the distribution of its first diagnostic test to the greatest number of people throughout France and internationally.
The team is also working on the development of new diagnostic tests and procedures in the field of women’s health to pursue research efforts in reproductive immunology.